April 30, 2024
Director's Voice Blog
A Q&A with WALS Lecturer Jenny Tung on her research with primates and advice for aspiring scientists
The NIH Director’s Wednesday Afternoon Lecture Series, colloquially known as WALS, is the highest-profile lecture program at the National Institutes of Health (NIH). The Office of Behavioral and Social Sciences Research (OBSSR) is honored that our nominee, Jenny Tung, Ph.D., was selected this year. As we look forward to her lecture on May 1, we asked Dr. Tung to share a little bit about her background, career, and research.
Behavioral and Social Sciences Research Spotlights
A New Model for Studying Social Isolation and Health in People with Serious Mental Illnesses
Researchers have developed a promising new framework for studying the link between social disconnection and poor physical health in people living with serious mental illnesses (SMI). Drawing on published research from animal models and data from the general population, this framework builds on existing social isolation and loneliness models by integrating insights from evolutionary and cognitive theories. This research was supported by OBSSR and the National Institute of Mental Health
Events
Registration Now Open for the Matilda White Riley Behavioral and Social Sciences Honors
Date and Time: May 20, 2024, 1:00-4:30 p.m.
Registration is now open for the 17th Matilda White Riley Behavioral and Social Sciences Honors. The event recognizes both emerging scientists and leaders in the field whose research reflects Dr. Matilda White Riley’s vision of research excellence in health-related behavioral and social sciences. Matilda White Riley was a celebrated scientist and member of the National Academy of Sciences whose transformative work and leadership left a lasting impact on behavioral and social sciences across NIH and beyond.
Join us for the Future of Scientific Conferencing Workshop
Dates and Times: June 6, 2024, 12:00–5:00 p.m. ET; June 7, 2024, 12:00–3:00 p.m. ET; June 11, 12:00–5:00 p.m. ET
The Future of Scientific Conferencing Workshop will bring together diverse perspectives from multiple disciplines to explore advantages, barriers, gaps, and opportunities in the future of scientific conferencing for the behavioral and social sciences. Areas of particular focus include technological innovations that enable virtual and hybrid approaches, and the impact of these approaches on diversity, equity, inclusion, accessibility, and belonging of participants and attendees as well as environmental sustainability. The workshop will incorporate innovative evidence-informed approaches to showcase the potential of a virtual platform for learning, networking, and participant engagement.
PATH Study Data User Workshop: Apply by 5/31 for the July/August 2024 Events
The National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) are sponsoring a Population Assessment of Tobacco and Health (PATH) Study Data User Workshop to further the understanding and use of PATH Study data files. The workshop is part of the 2024 ICPSR Summer Program. The in-person session will take place July 29-30 in Ann Arbor, Michigan. The virtual-only will take place August 15-16 via Zoom. Both workshop sessions offer the same content. To attend, apply by May 31. Enrollment is limited and admission to the workshop is competitive.
News
Deadline Extended: PAR-22-233 (Time-Sensitive Opportunities for Health Research)
The funding opportunity, Time-Sensitive Opportunities for Health Research (PAR-22-233), has been extended for an additional year. The funding opportunity aims to expedite the review and award process to support research focused on understanding health outcomes related to unexpected or time-sensitive events, such as emergent environmental threats and pandemics or changes in local, state, or national policies, as well as natural disasters. Please note that the OBSSR contact has changed to Rosalind King, Ph.D., Chief, Scientific Development and Coordination Section. The expiration date is March 2, 2025.
OBSSR Reissues the Notice of Funding Opportunity (NOFO) for the Training in Advanced Data and Analytics for Behavioral and Social Sciences Research (TADA-BSSR) Program
OBSSR, along with several other NIH Institutes, Centers, and Offices, has reissued a funding opportunity for the Training in Advanced Data Analytics for Behavioral and Social Sciences Research (TADA-BSSR) program. TADA-BSSR supports behavioral and social sciences research (BSSR) predoctoral training programs that focus on innovative computational or data science analytic approaches. The application period is now open and closes on May 24, 2024.
NIH ECHO Program Issues Request for Information on Potential Strategic Priorities as Part of Strategic Planning Process
NIH is seeking feedback on potential strategic priorities for the Environmental Influences on Child Health Outcomes (ECHO) Program through 2029. NIH welcomes researchers, advocates, clinicians, and the public to offer observational and intervention research priorities that ECHO can consider during its upcoming strategic planning process. Comments are due by Friday, May 31, 2024.
New PATH Study Data Files Release
NIDA and CTP have released the Wave 7 Restricted-Use File (RUF) from the Population Assessment of Tobacco and Health (PATH) Study. Wave 7 files contain data collected between January 2022 and April 2023, including questionnaire data, tobacco Universal Product Code (UPC) data, and state identifier data.
In addition, the PATH Study Biomarker Restricted-Use Files (BRUF) have been updated to include additional assays from Wave 4 and Wave 5. The PATH Study Restricted-Use Files (RUF) now include Wave 6 Ever/Never reference data for all participants. The Restricted-Use and Public-Use Master Linkage Files have each been updated to reflect the new RUF files and the current availability of biospecimens in the Biospecimen Access Program.
Research are encouraged to apply for access to the Restricted-Use Files and Biomarker Restricted-Use Files. Public-Use Files are also available for download.
Recently Published Funding Opportunities
Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
First available due date: May 24, 2024
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial Required—Infrastructure)
First available due date: June 14, 2024
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Next available due date: June 18, 2024
Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
First available due date: July 5, 2024
Topic Areas of Interest for Joint NIH/NSF Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO) Program
Next available due date: September 9, 2024
BSSR Accomplishments
The NIH has been an instrumental leader in shaping and supporting behavioral and social sciences research (BSSR) to improve the nation’s health. Integrated with advances in other scientific disciplines, BSSR has made substantial contributions to the prevention or treatment of numerous physical health and mental health conditions.
In collaboration with subject matter experts from Institutes, Centers, and Offices across NIH, OBSSR has summarized some of the important scientific advances that demonstrate the valuable contribution of BSSR across various health conditions and behaviors. These summaries are provided as fact sheets that highlight a significant public health problem and the corresponding BSSR-informed approaches used to address the problem. Various audiences such as academic researchers, public health organizations, and other health federal agencies, may find these materials useful to demonstrate to their stakeholders the importance of BSSR to the health of the United States population.
BSSR Clinical Trials Resources
Clinical Trials Protocol Template for the Behavioral and Social Sciences
The Clinical Trials Protocol Template for the Behavioral and Social Sciences is a resource for communicating the science, methods, and operations of a clinical trial. This template is a suggested format for clinical trials that are testing a behavioral or social intervention or experimental manipulation. Use of the protocol template is encouraged but not required.
Decision Support Tool: Features to Consider in Determining If a Clinical Trial is Phase II or Phase III
This document is the result of a working group led by OBSSR, with participants from other Institutes, Centers, and Offices. It is a designed to be a resource to help investigators, program officers, and reviewers determine if a behavioral or social science study is better characterized as a Phase II or a Phase III clinical trial. Distinguishing earlier phases of clinical trials (Phase 0 or I) is not usually difficult but distinguishing between a Phase II and III study can be more challenging, particularly for non-drug trials. Being thoughtful about this distinction is important for a variety of reasons, not least of which is that a Phase III designation for an NIH funded clinical trial generally requires following additional policies and practices beyond those that already apply to Phase II clinical trials, such as the requirement for valid analysis and for a Data and Safety Monitoring Board (DSMB).
Good Clinical Practice for Social and Behavioral Research eLearning Course
In September 2016, the NIH issued a Policy on Good Clinical Practice (GCP) Training for NIH Awardees Involved in NIH-funded Clinical Trials. GCP is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials. The principles of GCP help assure the safety, integrity, and quality of clinical trials.
Phase III Trials
NIH’s definition of a Phase III Clinical Trial is quite broad, including drug studies, device studies, behavioral interventions, epidemiological studies, community trials, and more. Phase III trials are usually large, prospective trials that compare two or more interventions against other standard or experimental interventions. In this next episode of our NIH All About Grants podcast (MP3 / Transcript) we explain what a Phase III trial is, how it compares to other types of clinical trials, considerations for your application and its review, how these studies influence standards of care, helpful tools and other resources, and much more.